Site Search

Displaying results 431 - 440 of 893

82nd Edition – September 2018

Newsletter Issue | September 2018

Table of contents:

Boosting the fight against drug-resistant bacteria in hospitals

News | 03/09/2018 |

Success stories from projects

IMI's COMBACTE-MAGNET project has built an extensive public-private network to speed up the development of treatments to combat antibiotic-resistant bacteria that cause infections in intensive care units, helping address a major issue for hospitals.

IMI at BIO-Europe 2018

Event | 05/11/2018 - 07/11/2018 | Copenhagen, Denmark

IMI teamed up with the European Commission to take part in BIO-Europe 2018 , which was held in Copenhagen, Denmark, on 5 to 7 November inclusive. In addition to a session on funding opportunities for small and medium-sized enterprises (SMEs), we had a stand at the exhibition ...

‘We found a way to share the unsharable’ – an interview with the eTOX project coordinators

News | 31/07/2018 |

Success stories from projects

The eTOX project partners developed innovative strategies and novel software tools to better predict the safety and side effects of new candidate medicines for patients. In an interview with the IMI Programme Office, project coordinator Francois Pognan of Novartis, and ...

AIMS-2-TRIALS

Project| Ongoing | IMI2 |
Autism

Autism Innovative Medicine Studies – 2 – Trials

81st Edition – July 2018

Newsletter Issue | July 2018

Table of contents:

IMI Stakeholder Forum 2018

Event | 24/10/2018 | Brussels, Belgium

The IMI Stakeholder Forum 2018 took place on Wednesday 24 October in Brussels at Hotel Crowne Plaza Le Palace. The theme this year was ’The value of cross-sectoral health research and innovation’ . The event also offered an opportunity to celebrate IMI’s 10th anniversary ...

New Antimicrobial Resistance Accelerator Programme part of latest IMI Calls for proposals

News | 18/07/2018 |

Press releases

Brussels, Belgium, 18 July 2018 – A new Antimicrobial Resistance (AMR) Accelerator Programme is part of new Calls for proposals launched today by the Innovative Medicines Initiative (IMI). Of the other topics launched in the Calls, many address brain disorders (e.g. Alzheimer’s ...

IMI2 - Call 16

Content | 16/07/2018

IMI2 – Call 16 was launched on 18 July 2018 with the following topics: Progress new assets (one pre-new molecular entity (preNME) and one first-time-in-human (FTIH) start) for tuberculosis (TB) that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors ...

IMI2 - Call 15

Content | 16/07/2018

IMI2 - Call 15 was launched on 18 July 2018 with the following topics: Integrated research platforms enabling patient-centric drug development Blockchain Enabled Healthcare Microenvironment imposed signatures in tissue and liquid biopsies in immune-mediated diseases Emerging ...